Steven Cohen’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$77.5K Sell
104,678
-603,313
-85% -$464K ﹤0.01% 3698
2026
Q2
$582K Buy
707,991
+663,270
+1,483% +$627K ﹤0.01% 3108
2026
Q1
$41.1K Sell
44,721
-98,586
-69% -$119K ﹤0.01% 3670
2025
Q4
$183K Buy
+143,307
New +$193K ﹤0.01% 3658
2024
Q2
– Sell
-142,300
Closed -$386K – 2174
2024
Q1
$386K Buy
+142,300
New +$344K ﹤0.01% 1710
2023
Q4
– Sell
-34,582
Closed -$100K – 2498
2023
Q3
$100K Buy
+34,582
New +$90.4K ﹤0.01% 1967
2020
Q3
– Sell
-399,415
Closed -$1.6M – 1012
2020
Q2
$1.6M Buy
+399,415
New +$1.39M 0.01% 626
2015
Q3
– Sell
-63,400
Closed -$1.53M – 844
2015
Q2
$1.53M Buy
+63,400
New +$2M 0.01% 590

Other funds holding LAB

Steven Cohen's LAB Position: Q3 2026 in Review

Steven Cohen reduced its Standard BioTools (LAB) stake by 85% in Q3 2026, selling an estimated $464K and leaving 104,678 shares worth $77.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3698.

Steven Cohen first reported a position in LAB in Q2 2015 and has held it in 8 quarters since. The position peaked at $1.6M in Q2 2020. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Steven Cohen held 104,678 shares of Standard BioTools worth $77.5K as of Q3 2026.
  • Steven Cohen sold 603,313 Standard BioTools shares in Q3 2026, an estimated $464K.
  • Standard BioTools made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3698 holding.
  • Steven Cohen first reported a position in Standard BioTools in Q2 2015 and has held it in 8 quarters since.
  • Steven Cohen's Standard BioTools position peaked at $1.6M in Q2 2020.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.